The flow cytometry-based assay measures the expression of the protein FcyR11a as a biomarker for cardiovascular risk.

Researchers have identified a new target to treat atherosclerosis, a condition where plaque clogs arteries and causes major cardiac issues, including stroke and heart attack.

People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...

Researchers at Case Western Reserve University have identified a new target to treat atherosclerosis, a condition where ...

Clogged arteries, also known as atherosclerosis, happen when plaque builds up inside the arteries, which are blood vessels that carry oxygen-rich blood throughout the body. Plaque is made of ...

Researchers at Case Western Reserve University have identified a new target to treat atherosclerosis, a condition where ...

Like a fire alarm sending signals to evacuate a smoky building, the immune system has internal guards to help the body sense and respond to danger. However, for people with risks for heart disease, ...

Atherosclerosis is a major cause of mortality throughout the western world, despite the existence of drugs that lower cholesterol. The incidences of obesity and type 2 diabetes are increasing at ...

And it turns out, said Garovic, “that indeed women who had preeclampsia and have MI actually have more atherosclerosis in ...

However, having too much suPAR appears to cause problems, particularly with the arteries. High levels of suPAR can lead to ...

The researchers found that 20 percent of participants reported work-related stress. Compared with those without work-related stress, participants with work-related stress had lower odds of having ...

It was originally developed in 2015 from participant data in the Multi-Ethnic Study of Atherosclerosis, a community-based ...